https://www.selleckchem.com/pr....oducts/zebularine.ht
96 ± 506.25 mean kcal/day and among MS participants was 585.37 ± 529.02 mean kcal/day; this represents a mean difference of 30 and 25%, respectively. This study established the feasibility and acceptability of ASA24 in persons with MS and provides a foundation regarding the need for further validation research examining appropriate outcomes for supporting dietary interventions. This study established the feasibility and acceptability of ASA24 in persons with MS and provides a foundation regarding the need for further validation resea
Like
Comment
Share
